Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCOSANOL vs DOLUTEGRAVIR\LAMIVUDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOCOSANOL vs DOLUTEGRAVIR\LAMIVUDINE: Safety Overview

Metric DOCOSANOL DOLUTEGRAVIR\LAMIVUDINE
Total FAERS Reports 7,855 3,176
Deaths Reported 0 116
Death Rate N/A 3.7%
Hospitalizations 27 335
Average Patient Age 53.9 yrs 47.5 yrs
% Female Patients 73.0% 28.2%
FDA Approval Date Jul 25, 2000 N/A
Manufacturer WALMART INC. (see also Equate) N/A
Route TOPICAL N/A
Marketing Status OTC N/A